EMEA RELEASES GUIDELINES FOR MEDICINES ON ALZHEIMER’S, CHRON’S AND PARKINSON’S DISEASES

BY KEITH NUTHALL

THE EUROPEAN Medicines Agency (EMEA) has released new guidelines for manufacturing pharmaceuticals treating Alzheimer's, Chron's and Parkinson's diseases. These new sets of formal advice are substantially different from earlier EMEA guidelines for medicines designed for these diseases, and "reflect new scientific understanding" said the European Union agency. They especially cover the kinds of tests and trials that should be carried out, helping manufacturers submit valid marketing approval applications to EMEA. "These ...


Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.